This archive contains the following articles listed by volume, issue and page number:
 |
|
|
Volume 15, 2011 Articles |
Title (Click for Details) |
Vol/Issue |
Page |
PreScription: The Resources of the International Journal of Pharmaceutical Compounding, Inc.; Sterile Compounding Meets Needs for Patients, Professionals |
Vol. 15 No. 1 |
4 |
Home Infusion 101 |
Vol. 15 No. 1 |
6 |
Current Concepts in the Treatment of Recurrent Aphthous Ulcers |
Vol. 15 No. 1 |
13 |
A Technology Guide for Evaluating Software Tools to Support Sterile Compounding and Workflow Management |
Vol. 15 No. 1 |
20 |
Goliath: Case Report on a Canine Case of Epilepsy |
Vol. 15 No. 1 |
27 |
Maillard Reactions in Pharmaceutical Formulations and Human Health |
Vol. 15 No. 1 |
32 |
Toxicities Associated with Topical Anesthetics |
Vol. 15 No. 1 |
41 |
Marketing Vitamins, Minerals, and Other Nutrients |
Vol. 15 No. 1 |
44 |
Quality-Control Analytical Methods: Endotoxins: Essential Testing for Pyrogens in the Compounding Laboratory, Part 3: A Simplified Endotoxin Test Method for Compounded Sterile Preparations |
Vol. 15 No. 1 |
49 |
Basics of Compounding: Basics of Compounding with Potency Designated Ingredients |
Vol. 15 No. 1 |
56 |
Calculations |
Vol. 15 No. 1 |
62 |
Diclofenac Sodium 10-mg/mL Oral Suspension |
Vol. 15 No. 1 |
64 |
Hydrocortisone Acetate 1% Gel, Alcohol-Free |
Vol. 15 No. 1 |
65 |
Ibuprofen 5% Gel |
Vol. 15 No. 1 |
66 |
Mandelic Acid 5% Cream |
Vol. 15 No. 1 |
67 |
Methotrexate 30-mg/g Topical Gel |
Vol. 15 No. 1 |
68 |
Piroxicam 1% Gel |
Vol. 15 No. 1 |
69 |
Pramoxine 1% Cream |
Vol. 15 No. 1 |
70 |
Sodium Nitroprusside and Sodium Thiosulfate Intravenous Admixture |
Vol. 15 No. 1 |
71 |
Terbenafine Hydrochloride Bilayer Nail Lacquer |
Vol. 15 No. 1 |
72 |
Vancomycin Hydrochloride 25-mg/mL Solution |
Vol. 15 No. 1 |
73 |
Stability of Midazolam Intranasal Formulation for the Treatment of Status Epilepticus in Dogs |
Vol. 15 No. 1 |
74 |
Chemical Stability of Brompheniramine Maleate in an Oral Liquid Dosage Form |
Vol. 15 No. 1 |
78 |
Stability of Venlafaxine Immediate-Release Suspensions |
Vol. 15 No. 1 |
81 |
PostScription: Profile of a Pharmacy Compounding Accreditation Board–Accredited Pharmacy: Vital Care of Meridian |
Vol. 15 No. 1 |
86 |
PreScription: Discontinued Drugs and Drug Shortages |
Vol. 15 No. 2 |
92 |
PreScription: Cabaleiro Brings Solid Record to the Pharmacy Compounding Accreditation Board |
Vol. 15 No. 2 |
92 |
Home Infusion Basics for the Non-Infusion Pharmacist |
Vol. 15 No. 2 |
94 |
Testosterone Levels in an Aging Population: Screen, Measure, and Restore |
Vol. 15 No. 2 |
102 |
Case Report: Clindamycin Hydrochloride 1% Otic Suspension in the Management of Otitis Externa in a Canine |
Vol. 15 No. 2 |
114 |
The Relevance of the Soviet Pharmaceutical Industry and Dispensing: Dependence on Traditional Compounding |
Vol. 15 No. 2 |
117 |
Proton Pump Inhibitor Homogenous Suspensions: A Compounding Solution to Pediatric Gastroesophageal Reflux Disease |
Vol. 15 No. 2 |
124 |
Seven Marketing Tactics That Don't Work |
Vol. 15 No. 2 |
130 |
Quality Control Analytical Methods: Aqua Pura: Water Purification Systems and United States Pharmacopeia Waters for the Compounding Pharmacy, Part 1 |
Vol. 15 No. 2 |
133 |
Basics of Compounding: Basics of Compounding with Inorganic Salts |
Vol. 15 No. 2 |
146 |
Calculations |
Vol. 15 No. 2 |
154 |
Acetylcysteine 1% or 10% Oral Solution |
Vol. 15 No. 2 |
156 |
Amitriptyline Hydrochloride 2%, Carbamazepine 2%, Gabapentin 10%, and Ketoprofen 2% Transdermal Gel |
Vol. 15 No. 2 |
157 |
Clopidogrel 5-mg/mL Oral Suspension |
Vol. 15 No. 2 |
158 |
Dextromethorphan Hydrobromide 15-mg Oral Film Strip |
Vol. 15 No. 2 |
159 |
Hank's Balanced Salt Solution (Stock Solution) |
Vol. 15 No. 2 |
160 |
Levamisole 25-mg/mL Oral Solution |
Vol. 15 No. 2 |
161 |
Mandl's Paint |
Vol. 15 No. 2 |
162 |
Massage Rub, Oil Free |
Vol. 15 No. 2 |
163 |
Oral Film Strip Vehicle |
Vol. 15 No. 2 |
164 |
Tea Tree Oil Acne Gel |
Vol. 15 No. 2 |
165 |
Nifedpine in Compounded Oral and Topical Preparations |
Vol. 15 No. 2 |
166 |
Stability of Droperidol 0.625 mg/mL Diluted with 0.9% Sodium Chloride Injection and Stored in Polypropylene Syringes |
Vol. 15 No. 2 |
170 |
PostScription: Commentary: Discussion on the Safety of Topical Prilocaine |
Vol. 15 No. 2 |
174 |
Erratum: Stability of Venlafaxine Immediate-Release Suspensions |
Vol. 15 No. 2 |
175 |
PreScription: Greed Does Not Pay! Makena, Lucentis, and Others |
Vol. 15 No. 3 |
180 |
PreScription: Making Things Right--Or Not? |
Vol. 15 No. 3 |
180 |
Home Infusion: Available Vascular Access Devices and Common Therapies |
Vol. 15 No. 3 |
183 |
Drug Compatibility and Stability in Dextrose vs Saline |
Vol. 15 No. 3 |
190 |
Case Report: The Use of Topical Concentrated Capsaicin Cream to Treat Erythromelalgia in a Pediatric Patient |
Vol. 15 No. 3 |
194 |
Extemporaneous Preparation of Sertraline Cream for Transdermal Administration |
Vol. 15 No. 3 |
200 |
Treatment Options for Psoriasis |
Vol. 15 No. 3 |
204 |
Case Report: The Use of Compounded Metronidazole to Treat Clostridial and Campylobacterial Enteritis in an English Bulldog Puppy |
Vol. 15 No. 3 |
214 |
Legislative/Regulatory Update from the International Academy of Compounding Pharmacists |
Vol. 15 No. 3 |
218 |
7 Marketing Tactics That Don't Work, Part 2 |
Vol. 15 No. 3 |
222 |
Quality Control Analytical Methods: Aqua Pura: Water Purification Systems and United States Pharmacopeia Waters for the Compounding Pharmacy, Part 2: USP Waters: Experts at the United States Pharmacopeia Answer Compounders' Questions |
Vol. 15 No. 3 |
224 |
Basics of Compounding: Basics of Compounding with Complex Organic Molecules |
Vol. 15 No. 3 |
234 |
Calculations |
Vol. 15 No. 3 |
240 |
Amitriptyline 4%, Dextromethorphan Hydrobromide 20%, and Tramadol Hydrochloride 5% in Pluronic Lecithin Organogel Gel |
Vol. 15 No. 3 |
242 |
Diclofenac Sodium 1% Topical Gel |
Vol. 15 No. 3 |
243 |
Ibuprofen 5% Topical Cream |
Vol. 15 No. 3 |
244 |
Ketoprofen 10%, Ibuprofen 10%, Cyclobenzaprine Hydrochloride 2%, and Piroxicam 2% in Pluronic Lecithin Organogel Gel |
Vol. 15 No. 3 |
245 |
Melatonin 1-mg/mL Oral Suspension |
Vol. 15 No. 3 |
246 |
Sport Body Cooler |
Vol. 15 No. 3 |
247 |
Tannic Acid 5% Alcohol Gel |
Vol. 15 No. 3 |
248 |
Triamcinolone 0.1% Lotion |
Vol. 15 No. 3 |
249 |
Triclosan 2% Topical Cream |
Vol. 15 No. 3 |
250 |
Wound Cleaner Solution |
Vol. 15 No. 3 |
251 |
Stability of Ertapenem in an Elastomeric Infusion Device |
Vol. 15 No. 3 |
252 |
Stability of Verapamil Hydrochloride in SyrSpend SF Compared to Sorbitol Containing Syrup and Suspending Vehicles |
Vol. 15 No. 3 |
255 |
Compatibility of Parenteral Furosemide with Seventeen Secondary Drugs Used in Standard Concentrations |
Vol. 15 No. 3 |
259 |
PostScription: Announcement |
Vol. 15 No. 3 |
262 |
PreScription: The Science and Technology of Hospital Pharmacy Newsletter |
Vol. 15 No. 4 |
268 |
PreScription: Two Lessons in 17-Hydroxyprogesterone |
Vol. 15 No. 4 |
268 |
Home Infusion: Overview of the Infusion Patient-Care Process |
Vol. 15 No. 4 |
270 |
Waterless Alcohol-based Hand Sanitizers for the Compounding Pharmacy |
Vol. 15 No. 4 |
278 |
Legislative/Regulatory Update from the International Academy of Compounding Pharmacists |
Vol. 15 No. 4 |
286 |
Impact of Conventional and Bioidentical Hormone Replacement Therapy on Cardiovascular and Breast Health: A Review |
Vol. 15 No. 4 |
290 |
Treating Inner Ear Disorders with Intratympanic Drug Administration |
Vol. 15 No. 4 |
302 |
Transdermals: The Skin as Part of a Drug Delivery System |
Vol. 15 No. 4 |
308 |
Folinic Acid, L-DOPA, and 5-hydroxytryptophan in Tetrahydrobiopterin Deficiency: Treatment Plan for a Pediatric Patient |
Vol. 15 No. 4 |
316 |
7 Marketing Tactics That Don't Work, Part 3 |
Vol. 15 No. 4 |
320 |
Quality-Control Analytical Methods: Using Purified Water for Reconstitutions |
Vol. 15 No. 4 |
322 |
Basics of Compounding: Implementing United States Pharmacopeia Chapter <795> Pharmaceutical Compounding--Nonsterile Preparations, Part 1 |
Vol. 15 No. 4 |
328 |
Calculations |
Vol. 15 No. 4 |
332 |
Anesthetic Nasal Ointment |
Vol. 15 No. 4 |
334 |
Citric Acid, Potassium Citrate, and Sodium Citrate Solution |
Vol. 15 No. 4 |
335 |
Cromolyn Sodium 50-mg/mL Oral Suspension |
Vol. 15 No. 4 |
336 |
Glycopyrrolate 0.5-mg/mL Oral Suspension |
Vol. 15 No. 4 |
337 |
Hydrocortisone 100-mg/60-mL Retention Enema |
Vol. 15 No. 4 |
338 |
Magnesium Sulfate Paste |
Vol. 15 No. 4 |
339 |
Methylprednisolone 4-mg/mL Oral Suspension |
Vol. 15 No. 4 |
340 |
Oxandrolone 1-mg/mL Oral Suspension |
Vol. 15 No. 4 |
341 |
Quetiapine Fumarate 40-mg/mL Nonaqueous Oral Suspension |
Vol. 15 No. 4 |
342 |
Riboflavin 5-mg/mL Oral Suspension |
Vol. 15 No. 4 |
343 |
Preparation and Characterization of a New Alternative Formulation of Sodium p-aminosalicylate |
Vol. 15 No. 4 |
344 |
PostScription: Natural Tragedies: Pharmacists are Integral Members of the Emergency Healthcare Team |
Vol. 15 No. 4 |
350 |
PreScription: Third-party Inequities and Discrimination |
Vol. 15 No. 5 |
356 |
PreScription: American Pharmacists Month: A Time for Taking Responsibility |
Vol. 15 No. 5 |
356 |
Infantile Hemangiomas, Part 1: Treatment with Oral Propranolol Hydrochloride |
Vol. 15 No. 5 |
358 |
Natural Tragedies: Planning for Disasters and Emergencies |
Vol. 15 No. 5 |
368 |
Lessons Learned from a Continuous Quality-Improvement Testing Program |
Vol. 15 No. 5 |
372 |
Magic Mouthwashes: A Literature Review and Discussion of Common Compositions |
Vol. 15 No. 5 |
376 |
Legislative/Regulatory Update from the International Academy of Compounding Pharmacists |
Vol. 15 No. 5 |
382 |
Updated Case Report: The Use of Topical Concentrated Capsaicin Cream to Treat Erythromelalgia in a Pediatric Patient |
Vol. 15 No. 5 |
386 |
7 Marketing Tactics That Don't Work |
Vol. 15 No. 5 |
388 |
Quality-Control Analytical Methods: Aqua Pura: Water Purification Systems and United States Pharmacopeia Waters for the Compounding Pharmacy, Part 3: Testimonials and Comparisons |
Vol. 15 No. 5 |
390 |
Basics of Compounding: Implementing United States Pharmacopeia Chapter <795> Pharmaceutical Compounding--Nonsterile Preparations, Part 2 |
Vol. 15 No. 5 |
408 |
Calculations |
Vol. 15 No. 5 |
416 |
Carvedilol 0.625-mg/mL Oral Liquid |
Vol. 15 No. 5 |
418 |
Granisetron Hydrochloride 0.2-mg/mL Oral Suspension |
Vol. 15 No. 5 |
419 |
Lorazepam 1-mg/mL Oral Suspension |
Vol. 15 No. 5 |
420 |
Metoprolol Tartrate 1.25-mg/mL Oral Liquid |
Vol. 15 No. 5 |
421 |
Nifedipine 1-mg/500-mg Oral Powder |
Vol. 15 No. 5 |
422 |
Nifedipine 10-mg/mL Oral Suspension |
Vol. 15 No. 5 |
423 |
Rebamipide Rectal Enema Suspension |
Vol. 15 No. 5 |
424 |
Sotalol 5-mg/mL Oral Suspension |
Vol. 15 No. 5 |
425 |
Sulfadiazine 100-mg/mL Oral Suspension |
Vol. 15 No. 5 |
426 |
Ursodiol 50-mg/mL Oral Suspension |
Vol. 15 No. 5 |
427 |
Study of Microbiological Safety of 25 Oncology Drugs After Multiple Uses in Aseptic Conditions |
Vol. 15 No. 5 |
428 |
Stability of Clopidogrel in Three Extemporaneously Compounded Oral Liquid Preparations |
Vol. 15 No. 5 |
435 |
PostScription: Compounders Go Above and Beyond in the Name of Safety |
Vol. 15 No. 5 |
438 |
PreScription: Not All Pharmacists Should Compound! |
Vol. 15 No. 6 |
444 |
PreScription: Compounding: Keeping Elephants Our of Our Mouseholes |
Vol. 15 No. 6 |
444 |
A Retrospective Observational Case Series Analysis of the Usage of Hydroxyprogesterone Caproate for the Prevention of Preterm Labor in Alabama Patients |
Vol. 15 No. 6 |
446 |
Compounding for Treatment of Equine Infectious Diseases: An Overview |
Vol. 15 No. 6 |
450 |
Infantile Hemangiomas, Part 2: Topical Treatment with Beta Blockers |
Vol. 15 No. 6 |
458 |
Diaper Rash Relief: Common Sense Remedies and Treatments |
Vol. 15 No. 6 |
464 |
Legislative/Regulatory Update from the International Academy of Compounding Pharmacists |
Vol. 15 No. 6 |
471 |
The International Academy of Compounding Pharmacists Debuts the Compounding Pharmacy Assessment Questionnaire |
Vol. 15 No. 6 |
474 |
Quality Control: Undecided About Buying an In-House Water Purification System? Pros, Cons, and Caveats That May Provide the Answers You Need |
Vol. 15 No. 6 |
480 |
Basics of Compounding: Implementing United States Pharmacopeia Chapter <795> Pharmaceutical Compounding--Nonsterile Preparations, Part 3 |
Vol. 15 No. 6 |
488 |
Calculations |
Vol. 15 No. 6 |
498 |
Cefepime 1% Ophthalmic Solution |
Vol. 15 No. 6 |
500 |
Citric Acid 3% Mouthrinse Solution |
Vol. 15 No. 6 |
501 |
Dapsone 5% Topical Gel |
Vol. 15 No. 6 |
502 |
Lavender Oil 4% in Polyethylene Glycol Ointment |
Vol. 15 No. 6 |
503 |
Morphine 6-mg/mL, Haloperidol 0.5-mg/mL, and Hyoscine 6-mg/mL Infusion |
Vol. 15 No. 6 |
504 |
Oxandrolone 2-mg/mL Oral Liquid |
Vol. 15 No. 6 |
505 |
Thioguanine 20-mg/mL Oral Suspension |
Vol. 15 No. 6 |
506 |
Tobramycin Fortified 13.5-mg/mL Ophthalmic Solution |
Vol. 15 No. 6 |
507 |
Vancomycin 31-mg/mL Ophthalmic Solution |
Vol. 15 No. 6 |
508 |
Vancomycin 2% in Silver Sulfadiazine Cream |
Vol. 15 No. 6 |
509 |
A New Proposal: Calculating Density Factors for Drugs Using Cocoa Butter as the Standard |
Vol. 15 No. 6 |
510 |
Physiochemical Stability of Diluted Trastuzumab Infusion Solutions in Polypropylene Infusion Bags |
Vol. 15 No. 6 |
515 |
Development and Statistical Analysis of Glipzide-Loaded Fast-Dissolving Tablets Using Plantago ovata Husk as a Superdisintegrant |
Vol. 15 No. 6 |
521 |
PostScription: Drug Disposal: Compounding Pharmacists' Involvement in the Prevention of Prescription Drug Misuse and Abuse |
Vol. 15 No. 6 |
526 |